all report title image

RIVAROXABAN MARKET ANALYSIS

Rivaroxaban Market, By Indication (Atrial Fibrillation, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Prophylaxis of Venous Thromboembolism (VTE), and Others), By Formulation (Tablets and Suspension), By Patient Type (Adults and Paediatrics), By Distribution Channel (Hospitals and Clinics, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Aug 2024
Code : CMI1962
Pages :150
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Rivaroxaban Market Concentration By Players

To learn more about this report, request sample copy

Key Players Insights

Bayer AG
Janssen Pharmaceuticals, Inc.
Interquim SA
Natco Pharma
Mylan N.V.
Sandoz (a Novartis division)
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma
Zydus Cadila
Apotex Inc.
Hetero Labs Limited
Fresenius Kabi AG
Sun Pharmaceutical Industries Ltd.
Lupin Pharmaceuticals
Reddy's Laboratories
Bristol-Myers Squibb
Merck & Co., Inc.
Pfizer Inc.
Eisai Co., Ltd.
Amgen Inc.

Rivaroxaban Market Report Snapshots

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Press Release

Global Rivaroxaban Market to Surpass US$ 26.11 Mn by 2031

Credibility and Certifications

ESOMAR

DUNS Registered

Clutch

DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.